Diffuse Systemic Sclerosis with Severe Complications in Multiple Organs
暂无分享,去创建一个
[1] R. Elashoff,et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. , 2007, American journal of respiratory and critical care medicine.
[2] G. Valentini,et al. Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy. , 2007, Clinical and experimental rheumatology.
[3] Sumio Watanabe,et al. A case of pseudoobstruction of the intestine associated with scleroderma dramatically responding to antibiotics , 2006, Journal of gastroenterology.
[4] Charlie Strange,et al. Cyclophosphamide versus placebo in scleroderma lung disease. , 2006, The New England journal of medicine.
[5] Y. Muro,et al. Improvement of Systemic Sclerosis Complicated with Interstitial Lung Disease by Intravenous Pulse Therapy with Cyclophosphamide , 2006 .
[6] A. Morelli,et al. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term. , 1994, The American journal of gastroenterology.